ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 24 filers reported holding ENVVENO MEDICAL CORPORATION in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | -98.9% | 21 | -99.3% | 0.00% | – |
| Q2 2023 | $9,926 | +141700.0% | 3,223 | +106.7% | 0.00% | – |
| Q1 2023 | $7 | -22.2% | 1,559 | -16.1% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 1,858 | -29.8% | 0.00% | – |
| Q3 2022 | $17,000 | +750.0% | 2,648 | +389.5% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 541 | +77.4% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 305 | -61.2% | 0.00% | – |
| Q4 2021 | $5,000 | – | 786 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 401,200 | $1,517,000 | 2.12% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $829,000 | 0.14% |
| Perceptive Advisors | 781,615 | $2,954,000 | 0.09% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 24,000 | $91,000 | 0.02% |
| UBS OCONNOR LLC | 118,113 | $446,000,000 | 0.01% |
| Sepio Capital, LP | 10,800 | $41,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,049 | $8,000 | 0.00% |
| NORTHERN TRUST CORP | 13,906 | $53,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 81,723 | $308,000 | 0.00% |